Medicine for treating neutral/oily skin chilblain and manufacturing method thereof

Abstract

The invention belongs to the technical field of medicine chemical engineering, and particularly relates to a medicine for treating neutral / oily skin chilblain, which is characterized by comprising the following raw materials in parts by weight: 6-12 parts of chili powder with the fineness of less than 150 meshes, 3-7 parts of Span-80, 4-8 parts of beeswax, 0.5-1.5 parts of eugenol, 4-8 parts of methyl salicylate, 1-3 parts of sheep horn powder or ox horn powder or buckhorn powder with the fineness of less than 150 meshes, 8-12 parts of lanonol, 4-6 parts of propanediol, 70-90 parts of paraffin oil, 80-120 parts of distilled water and 0.5-1.5 parts of propyl p-hydroxy benzoate. The invention also discloses a manufacturing method of the medicine for treating neutral / oily skin chilblain. The medicine is suitable for treating neutral / oily skin chilblain, and can heal the chilblain quickly; the manufacturing method is simple and easy to master; the medicine is fragrant, and the patient does not have any uncomfortable feeling or untoward effect in the application period.

Description

technical field [0001] The invention belongs to the technical field of medicine and chemical industry, and in particular relates to a medicine for treating frostbite of neutral and oily skin and a preparation method thereof. Background technique [0002] Chilblains are localized, erythematous inflammatory lesions resulting from exposure to subzero cold. Chilblain is an abnormal inflammatory response to a cold, humid, non-freezing environment, and histologically confirmed chilblain is a lymphocytic vasculitis. Exposure to cold and humid environments is the main risk factor for chilblain, which mostly occurs in autumn and winter, especially when the temperature drops sharply in winter and the environment is humid in temperate climate areas, chilblain is more common. Most common in areas without central heating. Women, children, and the elderly are often affected, and children may be associated with cryoglobulins or cold agglutinins. It manifests as single or multiple swolle...

AI Technical Summary

Problems solved by technology

[0003] Domestic research on frostbite drugs has been done for many years and has a large number of research results, such as the patent number: 200710168576.9, the name of the invention: a kind of external medicine for preventing and treating chilblain; Oil liniments; etc., however, really aren't great for chilblains, and aren't tailored for people with normal and oily skin, so less effective